MMedication Read More Pharmalittle: GLP-1s seen as lifestyle drugs; Merck, Daiichi setbackSeptember 29, 2026 Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating.…
HHealthcare Read More Gifts from pharma companies keep on giving, a new study findsSeptember 13, 2026 Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
HHealthcare Read More How major hospitals are embracing AI chatbots to query patient recordsAugust 21, 2026 Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
MMedication Read More Amylyx endocrine drug succeeds in key study for low blood sugarAugust 18, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
MMedication Read More Enveda weight loss maintenance pill mimics exercise in early testsAugust 18, 2026 If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
MMedication Read More Eli Lilly to offer retatrutide access given earlier to just one patientAugust 4, 2026 Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
MMedication Read More Pharmalittle: Novo discloses setback, Replimune drug endorsedJuly 31, 2026 And so, another working week will soon come to a close. Not a moment too soon, yes? This…
HHealthcare Read More Can doctors trust clinical AI? The complicated issue of LLM benchmarksJuly 30, 2026 Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
MMedication Read More Pharmalittle: FDA panel nixed Duchenne drug, Hims & Hers sued| STATJuly 30, 2026 Top of the morning to you, and a fine one it is. Skies are gray but rain is…
MMedication Read More Pharmalittle: RFK Jr. pushes against SSRIs, wearable drug okayedJuly 14, 2026 Good morning, everyone, and welcome to another working week. And of course, it is nice to see you…
MMedication Read More Pharmalittle: We’re reading about weight loss drug spending, launch prices for medicines, and much moreJune 25, 2026 Top of the morning to you, and a fine one it is. Clear, blue skies and mild breezes…
HHealthcare Read More Cadence raises $100 million to automate chronic disease care with regulated AIJune 24, 2026 Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech;…